From July 1, 2021 to December 31, 2021, the company has repurchased 696,000 shares, representing 0.44% for CNY 23.83 million. With this, the company has completed the repurchase of 2,273,523 shares, representing 1.44% for CNY 79.31 million under the buyback announced on January 21, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.17 CNY | -0.36% | -5.51% | -20.77% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.77% | 664M | |
+31.95% | 694B | |
+29.51% | 593B | |
-1.72% | 371B | |
+19.24% | 331B | |
+6.74% | 290B | |
+14.17% | 239B | |
-3.11% | 209B | |
+9.99% | 209B | |
+8.35% | 169B |
- Stock Market
- Equities
- 603590 Stock
- News Beijing Konruns Pharmaceutical Co.,Ltd.
- Tranche Update on Beijing Konruns Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on January 21, 2021.